KR860002576A - 신규 항생 물질 화합물의 제조방법 - Google Patents

신규 항생 물질 화합물의 제조방법 Download PDF

Info

Publication number
KR860002576A
KR860002576A KR1019850006691A KR850006691A KR860002576A KR 860002576 A KR860002576 A KR 860002576A KR 1019850006691 A KR1019850006691 A KR 1019850006691A KR 850006691 A KR850006691 A KR 850006691A KR 860002576 A KR860002576 A KR 860002576A
Authority
KR
South Korea
Prior art keywords
compound
compounds
microorganism
formula
prepared
Prior art date
Application number
KR1019850006691A
Other languages
English (en)
Other versions
KR940004098B1 (ko
Inventor
배리 와드(외 4) 죤
Original Assignee
원본 미기재
글락소 그룹리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848423278A external-priority patent/GB8423278D0/en
Priority claimed from GB848432519A external-priority patent/GB8432519D0/en
Application filed by 원본 미기재, 글락소 그룹리미티드 filed Critical 원본 미기재
Publication of KR860002576A publication Critical patent/KR860002576A/ko
Application granted granted Critical
Publication of KR940004098B1 publication Critical patent/KR940004098B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

내용 없음

Description

신규 항생 물질 화합물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 인자 A의 IR스펙트럼을 나타낸 것임.
제2도는 인자 B의 IR스펙트럼을 나타낸 것임.
제3도는 인자 C의 IR스펙트럼을 나타낸 것임.

Claims (26)

  1. 스트랩토 마이세스속의 미생물을 배양시켜서 하기 화합물을 제조하고, 이어서, 필요에 따라서 발효액으로 부터 하기 구조식(Ⅰ)의 화합물중 적어도 1개 이상의 화합물을 분리시킴을 특징으로 하는 하기 부분 구족식(Ⅰ)을 갖는 화합물의 제조방법.
  3. 제1항에 있어서, 하기 부분 구조식(Ⅱ)을 갖는 화합물을 제조하는 방법.
  5. 제2항에 있어서, 하기 일반식(Ⅲ)을 갖는 화합물을 제조하는 방법.
  7. (식중, R1은 메틸, 에틸 또는 이소프로필기이고, R2는 수소 또는 메틸기임.)
  8. 제3항에 있어서, 제조된 화합물중 R1이 이소프로필기이고, R2가 수소인 방법.
  9. 제3항에 있어서, 제조된 화합물중 R1이 메틸기이고, R2가 수소인 방법.
  10. 전 항중 어느 한 항에 있어서, 미생물이 주로 제1항에서 정의한 바와 같은 구조식(Ⅰ)의 화합물중 1개 이상의 화합물을 생성하는 방법.
  11. 전 항중 어느 한 항에 있어서, 미생물이 스트렙토마이세스 더모아르카엔시스인 방법.
  12. 전 항중 어느 한 항에 있어서, 미생물이 스트렙토마이세스속 더모아르카엔시스 NCIB 12015또는 그의 돌연변이체인 방법.
  13. 전 항중 어느 한 항에 있어서, 미생물이 스트렙토마이세스 더모아르카엔시스 NCIB 12111, NCIB12112, NCIB 12113 또는 NCIB 12114 또는 그의 돌연변이체인 방법.
  14. 전 항중 어느 한 항에 있어서, 미생물을 20°-50℃에서 배양시키는 방법.
  15. 전 항중 어느 한 항에 있어서, 미생물을 pH 5.5 내지 8.5에서 발효시키는 방법.
  16. 전 항중 어느 한 항에 있어서, 미생물을 2 내지 10일동안 발효시키는 방법.
  17. 전 항중 어느 한 항에 있어서, 미생물의 균사를 물과 혼화시킬수 있는 용매와 접촉시켜서 그로부터 제1항의 화합물중 1개이상의 화합물을 추출시키는 방법.
  18. 전 항중 어느 한 항에 있어서, 일반식(Ⅰ)의 화합물을 실질적으로 순수한 형태로 제조하는 방법.
  19. 제1 내지 13항중의 어느 한 항에 있어서, 일반식(Ⅰ)의 화합물을 실질적으로 기타 마크로리드 화합물의 부재하에서 제조하는 방법.
  20. 제1 내지 13항중의 어느 한 항에 있어서, 제3항에서 정의된 바와 같은 화합물의 혼합물, 또는 R2가 수소인 제3항에서 정의된 바와 같은 화합물들의 혼합물, 또는 R2가 메틸기인 제3항에서 정의된 바와 같은 화합물들의 혼합물을 제조하는 방법.
  21. 제1 내지 12항중의 어느 한 항에 있어서, 생성물이 제1항에서 정의한 바와 같은 구조식(Ⅰ)의 1가지 상의 화합물을 함유하는 완전한 발효액, 이와 같은 완전한 발효액의 고상물, 발효액으로부터 분리시킨 손상되지 않거나 또는 용해된 균사, 손상되지 않거나 또는 용해된 균사를 분리시킨 후 발효액의 고상물, 또는 균사를 분리시킨 후의 발효액 형태인 방법.
  22. 제1-5항중 어느 하나에서 정의한 1개 이상의 화합물과 1개이상의 담체 또는 부형체, 필요에 따라서 1개 이상의 첨가제, 또는 추가 유효성분을 혼합하거나 또는 다른 방식으로 제제해서 감염 또는 침습을 방제하기 위한 조성물의 제조방법.
  23. 제1-5항중 어느 하나에서 정의한 1개 이상의 화합물의 유효량을 감염, 침습 또는 그 부위에 원인이 되는 기생충, 기타 해충, 진균류 또는 미생물에 사용해서 감염 또는 침습(예, 농업, 원예 또는 임업)을 방제시키는 방법.
  24. 제19항에 있어서, 상기 화합물을 식물, 기타 초목, 또는 선택된 그 부위에 사용하는것을 특징으로 하는 방법.
  25. 제19 내지 20항에 있어서, 상기 기생충이 곤충, 진드기, 또는 선충류, 해충인 방법.
  26. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850006691A 1984-09-14 1985-09-13 신규 항생제 화합물의 제조 방법 KR940004098B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8423278 1984-09-14
GB848423278A GB8423278D0 (en) 1984-09-14 1984-09-14 Antibiotic compounds
GB8432519 1984-12-21
GB848432519A GB8432519D0 (en) 1984-12-21 1984-12-21 Antibiotic compounds

Publications (2)

Publication Number Publication Date
KR860002576A true KR860002576A (ko) 1986-04-26
KR940004098B1 KR940004098B1 (ko) 1994-05-13

Family

ID=26288220

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850006691A KR940004098B1 (ko) 1984-09-14 1985-09-13 신규 항생제 화합물의 제조 방법

Country Status (33)

Country Link
US (2) US4898821A (ko)
JP (2) JPH07116199B2 (ko)
KR (1) KR940004098B1 (ko)
AT (1) AT396250B (ko)
AU (1) AU596565B2 (ko)
BE (1) BE903232A (ko)
BG (1) BG44205A3 (ko)
BR (1) BR8504457A (ko)
CA (1) CA1313155C (ko)
CH (1) CH666690A5 (ko)
CS (1) CS268803B2 (ko)
DE (1) DE3532794A1 (ko)
DK (1) DK162099C (ko)
ES (2) ES8704545A1 (ko)
FI (1) FI87366C (ko)
FR (1) FR2570390B1 (ko)
GB (1) GB2166436B (ko)
GR (1) GR852232B (ko)
HU (1) HU197046B (ko)
IE (1) IE59394B1 (ko)
IL (1) IL76385A (ko)
IT (1) IT1182857B (ko)
LU (1) LU86074A1 (ko)
NL (1) NL8502511A (ko)
NZ (1) NZ213463A (ko)
PH (2) PH21995A (ko)
PL (1) PL152148B1 (ko)
PT (1) PT81125B (ko)
RO (1) RO92478A (ko)
SE (2) SE502748C2 (ko)
SU (1) SU1738090A3 (ko)
UA (1) UA19162A (ko)
ZW (1) ZW15585A1 (ko)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV5536A3 (lv) * 1984-09-14 1994-03-10 American Cyanamid Co Panemiens antibiotikas s-541 iegusanai streptomicetu celmi-antibiotikas s-541 producenti
US4696922A (en) * 1984-11-26 1987-09-29 Ciba-Geigy Corporation 5-azolylacetoxymilbemycins as ecto- and endoparasites
AT399441B (de) * 1985-04-30 1995-05-26 American Cyanamid Co Schädlingsbekämpfungsmittel und verfahren zur bekämpfung von schädlingen
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
EP0215654B1 (en) * 1985-09-13 1995-03-15 American Cyanamid Company Macrolide antibiotics and their preparation
AT398312B (de) * 1986-03-12 1994-11-25 American Cyanamid Co Verfahren zur herstellung einer neuen makroliden verbindung
NZ219575A (en) * 1986-03-12 1990-04-26 Glaxo Group Ltd Phosphate, substituted alkoxy, or amino-carbonyloxy derivatives of milbemycin, and pesticidal compositions
GB8606116D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Process
GB8606120D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Process
DE3707859A1 (de) * 1986-03-12 1987-10-08 Glaxo Group Ltd Makrolidverbindung
GB8606105D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Chemical compounds
GB8613790D0 (en) * 1986-06-06 1986-07-09 Glaxo Group Ltd Chemical compounds
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
US5840704A (en) * 1986-07-16 1998-11-24 Pfizer Inc. Antiparasitic agents and process for their preparation
NZ221077A (en) * 1986-07-18 1990-06-26 Ciba Geigy Ag 13b-alkyl milbemycins and use as parasiticides
EP0254583B1 (en) * 1986-07-24 1994-09-07 Beecham Group Plc Parasiticidal milbemycin derivatives, a process for their production, and compositions containing the same
US5149832A (en) * 1986-09-12 1992-09-22 American Cyanamid Company Mono and diacyl derivatives of ll-f28249 compounds
ATE109783T1 (de) * 1986-09-12 1994-08-15 American Cyanamid Co 23-oxo(keto) und 23-imino-derivate von ll-f28249- verbindungen.
EP0262384B1 (en) * 1986-09-12 1992-11-04 American Cyanamid Company 23-deoxy derivatives of ll-f28249 compounds
US5019589A (en) * 1986-09-12 1991-05-28 American Cyanamid Company Δ23 -LL-F28249 compounds
US4886828A (en) * 1986-09-12 1989-12-12 American Cyanamid Company Δ22 -derivatives of LL-F28249 compounds
US4916154A (en) * 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US5525506A (en) * 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5238848A (en) * 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5183749A (en) * 1987-02-04 1993-02-02 Sankyo Company, Ltd. Microbial process for the preparation of milbemycin derivatives
US4897416A (en) * 1987-02-18 1990-01-30 Ciba-Geigy Corporation Insecticides and parasiticides
US4876272A (en) * 1987-03-06 1989-10-24 American Cyanamid Company Mono- and diepoxide derivatives of LL-F28249 compounds
US4886830A (en) * 1987-03-06 1989-12-12 American Cyanamid Company Mono- and diepoxide derivatives of 23-deoxyl-LL-F28249 compounds
US4886829A (en) * 1987-03-06 1989-12-12 American Cyanamid Company 23-Oxo (keto) and 23-imino derivatives of mono- and diepoxy LL-F28249 compounds
US4851428A (en) * 1987-03-06 1989-07-25 American Cyanamid Company Mono- and diepoxide derivatives of Δ22-LL-F28249 compounds
US4956479A (en) * 1987-03-06 1990-09-11 American Cyanamid Company 23-deoxy-27-chloro derivatives of LL-F28249 compounds
US4855317A (en) * 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4806527A (en) * 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
GB8721377D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical compounds
GB8721378D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721375D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
US5240850A (en) * 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
CA1340771C (en) * 1987-11-09 1999-09-28 Shih-Jen Edward Lee Ethylated avermectins
GB8726730D0 (en) 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
GB8805978D0 (en) * 1988-03-14 1988-04-13 Glaxo Group Ltd Process
GB8813760D0 (en) * 1988-06-10 1988-07-13 American Cyanamid Co Chemical process
NZ232422A (en) * 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
US5322692A (en) * 1989-02-28 1994-06-21 American Cyanamid Company Sustained release bolus effective for the prolonged prevention, treatment or control of nematode, acarid and endo- and ectoparasitic infestations of ruminants
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
ES2052173T3 (es) * 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
DK0426948T3 (da) 1989-08-11 1996-05-28 American Cyanamid Co Arylpyrroler som insekticide, acaricide og nematodicide midler samt fremgangsmåder til deres fremstilling
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5830875A (en) * 1989-10-30 1998-11-03 Merck & Co., Inc. 24-and 25-substituted avermectin and milbemycin derivatives
US5055454A (en) * 1989-10-30 1991-10-08 Merck & Co., Inc. 13-epi-avermectin derivatives useful as antiparasitic agents
US5208222A (en) * 1991-03-28 1993-05-04 Merck & Co., Inc. 4"-and 4'-alkylthio avermectin derivatives
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
MD24B1 (ro) * 1991-07-09 1994-05-31 Parfumerii Si Cosmetice Vioric Compozitie de substante odorante
GB9205007D0 (en) * 1992-03-07 1992-04-22 Pfizer Ltd Antiparasitic agents
US5229415A (en) * 1992-03-24 1993-07-20 Merck & Co., Inc. Alkylthio alkyl avermectins are active antiparasitic agents
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
US6486195B1 (en) * 1993-08-19 2002-11-26 Merck & Co., Inc. Thermodynamically stable crystal form of 4″-deoxy-4″-epi-methylamino avermectin B1a/B1b benzoic acid salt and processes for its preparation
JP2855181B2 (ja) 1993-12-10 1999-02-10 敏雄 鈴木 松類の枯損防止用組成物及び防止方法
US6495591B1 (en) 1997-10-02 2002-12-17 Essential Therapeutics, Inc. Fungal efflux pump inhibitors
PT1197215E (pt) 2000-10-10 2006-07-31 Wyeth Corp Composicoes antelminticas
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
WO2006091038A1 (en) * 2005-02-25 2006-08-31 Medigenes Co., Ltd. Pharmaceutical composition for treating avellino cornea dystrophy comprising blood plasma or serum
CN100394983C (zh) * 2006-01-09 2008-06-18 浙江海正药业股份有限公司 含有大豆油的多拉菌素注射液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (ko) * 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
PH16612A (en) * 1977-12-19 1983-11-28 Merck & Co Inc 13-halo and 13-deoxy derivatives of c-076 compounds
US4173571A (en) * 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
US4171314A (en) * 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
US4200581A (en) * 1978-08-04 1980-04-29 Merck & Co., Inc. Alkyl derivatives of C-076 compounds
NZ201681A (en) * 1981-09-03 1985-11-08 Merck & Co Inc Avermectin derivatives and parasiticidal compositions
PT80577B (pt) * 1984-06-05 1987-09-18 American Cyanamid Co Processo para a producao de novos agentes macrolidos ll-f28249 uteis no tratamento de infeccoes helminticas por ectoparasitas artropodes e por acarideos
ES8802229A1 (es) * 1985-04-30 1988-04-16 Glaxo Group Ltd Un procedimiento para preparar nuevos derivados lactonicos macrociclicos.
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina

Also Published As

Publication number Publication date
JPH07213278A (ja) 1995-08-15
GB2166436A (en) 1986-05-08
ES8704545A1 (es) 1987-04-01
ES8802555A1 (es) 1988-08-01
DK162099C (da) 1992-02-24
IL76385A0 (en) 1986-01-31
ZW15585A1 (en) 1986-04-23
IE852263L (en) 1986-03-14
BR8504457A (pt) 1986-07-15
JPS61118387A (ja) 1986-06-05
HUT39779A (en) 1986-10-29
UA19162A (uk) 1997-12-25
SE502748C2 (sv) 1995-12-18
PL152148B1 (en) 1990-11-30
IE59394B1 (en) 1994-02-23
GR852232B (ko) 1986-01-14
AT396250B (de) 1993-07-26
JP2566385B2 (ja) 1996-12-25
GB8522699D0 (en) 1985-10-16
FR2570390B1 (fr) 1987-11-27
IT8548551A0 (it) 1985-09-13
FI87366B (fi) 1992-09-15
CS654685A2 (en) 1989-08-14
SE8504254D0 (sv) 1985-09-13
ATA268485A (de) 1992-11-15
SU1738090A3 (ru) 1992-05-30
DK418085D0 (da) 1985-09-13
KR940004098B1 (ko) 1994-05-13
FI87366C (fi) 1992-12-28
US4898821A (en) 1990-02-06
IL76385A (en) 1990-09-17
HU197046B (en) 1989-02-28
PT81125B (pt) 1987-10-20
AU4742685A (en) 1986-03-20
RO92478A (ro) 1987-09-30
ES557237A0 (es) 1988-08-01
FR2570390A1 (fr) 1986-03-21
FI853520L (fi) 1986-03-15
ES546962A0 (es) 1987-04-01
SE8802985D0 (sv) 1988-08-25
DK418085A (da) 1986-03-15
CH666690A5 (de) 1988-08-15
CA1313155C (en) 1993-01-26
DE3532794A1 (de) 1986-04-17
BG44205A3 (en) 1988-10-14
DK162099B (da) 1991-09-16
US4935531A (en) 1990-06-19
BE903232A (fr) 1986-03-13
SE8504254L (sv) 1986-03-15
PT81125A (en) 1985-10-01
SE469173B (sv) 1993-05-24
CS268803B2 (en) 1990-04-11
JPH07116199B2 (ja) 1995-12-13
PL255360A1 (en) 1988-02-18
IT1182857B (it) 1987-10-05
LU86074A1 (fr) 1986-04-03
SE8802985L (sv) 1988-08-25
AU596565B2 (en) 1990-05-10
PH21995A (en) 1988-05-02
NZ213463A (en) 1993-04-28
FI853520A0 (fi) 1985-09-13
GB2166436B (en) 1989-05-24
PH24247A (en) 1990-05-04
NL8502511A (nl) 1986-04-01

Similar Documents

Publication Publication Date Title
KR860002576A (ko) 신규 항생 물질 화합물의 제조방법
US3984564A (en) Antibiotic substances B-41, their production and their use as insecticides and acaricides
Khokhlov et al. Effect of A‐factor on the growth of asporogenous mutants of Streptomyces griseus, not producing this factor
US3950360A (en) Antibiotic substances
DE3051175C2 (ko)
KR860008205A (ko) 마크로리드 항생 물질의 제조 방법
DE68928606T2 (de) Antiparasitäre Makrolid-Antibiotika
KR870002253A (ko) 펩타이드 항생제
US3992551A (en) Antisiotic substances B-41, their production and their use as insecticides acaricides
US4869901A (en) Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
US4973552A (en) Staurosporine fermentation process
CA1109406A (en) Production of monorden
US3992552A (en) Antibiotic substance B-41, their production and their use as insecticides and acaricides
DE3243924C2 (ko)
KR900004939A (ko) 농화학적으로 유용한 활성 성분들의 미생물에 의한 제조 방법
CA1325395C (en) Macrolide compound
US3966914A (en) Antibiotic substances B-41, their production and their use as insecticides and acaricides
US5397570A (en) Antibiotics AB-023 and process for preparing them
US3271253A (en) Antibiotic ossamycin and method of preparing same
US5198464A (en) Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
US3998699A (en) Antibiotic substances B-41, their production and their use as insecticides and acaricides
US4385065A (en) Novel substances and process for their production
US3803307A (en) Antibiotic sl 21429
KR100360675B1 (ko) 사이클로스포린a제조방법
US3992527A (en) Antibiotic substances B-41, their production and their use as insecticides and acaricides

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970402

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee